SCHEMBL8511385

SCHEMBL8511385

COC(=O)C(CC(=O)O)=C(c1ccc(C(C)(C)C)cc1)c1ccc(OC)c(OC)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
LMNA P02545 2/20 0.57
KDM4E B2RXH2 1/20 0.57
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
NR1H4 Q96RI1 4/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
CA7 P43166 1/20 0.47
TPMT P51580 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
MAPT P10636 3/20 0.46
TP53 P04637 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8511383 1.00 ALDH1A1 (0.57) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL6131985 0.89 CA12 (0.57) ALDH1A1MEN1KMT2ANR1H4CA12
SCHEMBL3961238 0.89 MAPT (0.49) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL1331951 0.87 CA12 (0.51) ALDH1A1KDM4EMEN1KMT2ACA12
SCHEMBL1331949 0.87 CA12 (0.51) ALDH1A1KDM4EMEN1KMT2ACA12
SCHEMBL4367722 0.85 SMPD1 (0.52) ALDH1A1NR1H4CA12CA1CA2
SCHEMBL4367720 0.85 SMPD1 (0.52) ALDH1A1NR1H4CA12CA1CA2
SCHEMBL1011068 0.84 SMN1; SMN2 (0.54) ALDH1A1LMNAMEN1KMT2ACA12
SCHEMBL1960540 0.83 MAPT (0.46) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL29664077 0.83 MAPT (0.46) ALDH1A1LMNAKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139552-B2 Indeno-fused naphthopyrans having ethylenically unsaturated groups TRANSITIONS OPTICAL, INC. (US) 2015-09-22 US disclosed
WO-2013090220-A1 INDENO-FUSED NAPHTHOPYRANS HAVING ETHYLENICALLY UNSATURATED GROUPS PPG INDUSTRIES, INC. (US) 2013-06-20 WO disclosed
US-20120132870-A1 Indeno-Fused Naphthopyrans Having Ethylenically Unsaturated Groups TRANSITIONS OPTICAL INC. (US) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120132870-A1 Indeno-Fused Naphthopyrans Having Ethylenically Unsaturated Groups ACR, INTS6, B3GNT2 ALDH1A1 318/4885LMNA 312/4885KDM4E 4723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.